L
LABT
Lakewood-Amedex
0.6680
-0.0070-1.04%After Hours: 0.6543 -0.0137 -2.05%19:49 06/05 EDT
OPEN/PREV CLOSE0.6990/0.6750
TODAY RANGE0.6201-0.7095
VOL355.48K
MARKET CAP9.57M
52 WEEK RANGE0.5900-9.82
AVG VOL (3M)3.30M
% TURNOVER2.48%
TURNOVER--
P/E (TTM)-2.4860
% RANGE13.24%
EPS(TTM)-0.2687
P/E(FORWARD)--
P/B-4.8688
BVPS-0.1372
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.87M
SHARES OUTSTANDING14.32M
NEXT EARNINGS--
FREE FLOAT5.80M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/29 18:11
Lakewood-Amedex Biotherapeutics building broad antimicrobial platform, CEO says
TipRanks·05/29 18:10
Lakewood-Amedex CEO says going public boosts visibility, engagement
TipRanks·05/29 18:09
Bisphosphocin technology offers differentiated approach, Cooper says
TipRanks·05/29 18:05
Meet Lakewood-Amedex Biotherapeutics: Fly exclusive with CEO Kelvin Cooper
TipRanks·05/27 14:34
Lakewood-Amedex Biotherapeutics issued two new patents
PUBT·05/22 20:55
Lakewood-Amedex Q1 FY26 net loss widens to $923,291
Benzinga·05/20 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·05/18 14:11
Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update
TipRanks·05/18 12:12
Lakewood-Amedex Biotherapeutics advances production of foot ulcer candidate Nu3